Skip to content
Menu

Ligand Pharmaceuticals Incorporated LGND

Full chart Compare
Set alert

Price alert · LGND

All alert types
307.46 USD -1.33 (-0.43%)

As ofNov 16, 2026, 12:08 PM EST

306.12 Day range 313.76
175.89 52-week range 326.63
YTD
+62.62%
1 year
+53.07%

Revenue & Expenses

Revenue Profit Costs
Other Income$111.76MGross Profit$261.50MCost of Revenue$6.59MGross Profit & Other Income$373.26MNet Income$124.45MSelling, General & Admin$92.45MResearch & Development$81.18MOther Operating Expenses$40.67MIncome Tax$34.51MRevenue$268.09M

Latest period ending Dec 31, 2025 · select a line to chart its full history

LGND annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
268.09M167.13M131.31M196.25M241.54M
253.54M156.06M120.80M143.42M179.37M
41.00M-22.61M11.94M3.04M103.85M
124.45M-4.03M52.15M-33.36M57.14M
6.13-0.222.94-1.983.31
LGND annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
174.93M72.31M22.95M45.01M19.52M
1.56B941.77M787.22M762.67M1.30B
543.42M111.33M86.30M165.18M476.43M
451.49M7.08M6.17M87.75M324.39M
1.02B830.44M700.91M597.49M821.16M
LGND annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
49.36M97.05M49.58M137.85M78.80M
-377.32M-143.66M-11.68M163.62M30.52M
428.22M97.14M-59.95M-275.99M-137.76M
-1.26M-1.82M-3.52M-17.92M-8.27M
102.62M49.35M-22.05M25.48M-28.44M